
Articles by The Wall Street Analyzer


Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryteTM for the Treatment of Cutaneous T-Cell Lymphoma
FLASH2 Study opens patient enrollment Princeton, NJ – December 16, 2024 – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical […]

HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment
Significant Efficacy against Plaque Lesions Also Demonstrated with HyBryte™ PRINCETON, N.J., Dec. 2, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare […]

Peer to Peer Network (OTC: PTOP) Announces Strategic Partnership With Pantheon Technologies to Integrate AI-Powered ARES System Into MOBICARD(TM) Platform
CAMBRIDGE, MA / ACCESSWIRE / November 19, 2024 / Peer To Peer Network, Inc. (OTC:PTOP) is excited to announce a strategic partnership with Pantheon Technologies Inc., an emerging leader in AI technology, which will further elevate PTOP’s […]

PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
IRVINE, CA / ACCESSWIRE / October 31, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2025 first quarter ended September 30, 2024. The Company also filed its Quarterly Report on Form 10-Q […]





Midnight Sun Announces Start of Kazhiba Exploration Program
Vancouver, British Columbia–(Newsfile Corp. – September 19, 2024) – Midnight Sun Mining Corp. (TSXV: MMA) (OTC Pink: MDNGF) (“Midnight Sun” or the “Company”) announces the start of exploration work at the Kazhiba Target located on […]